Compounds > daunorubicin
Page last updated: 2024-08-23

daunorubicin and bromotetrandrine

daunorubicin has been researched along with bromotetrandrine in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's6 (54.55)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, BA; Chen, WJ; Cheng, J; Ding, JH; Gao, C; Gao, F; Li, GH; Li, XM; Liu, LJ; Shen, MF; Sun, XC; Wang, XM; Xu, WL1
Chen, BA; Chen, WJ; Cheng, J; Ding, JH; Gao, C; Gao, F; Li, GH; Li, XM; Liu, LJ; Sun, XC; Wang, XM; Wu, YN; Xu, WL1
Chen, B; Chen, N; Chen, W; Cheng, H; Cheng, J; Ding, J; Gao, C; Gao, F; Li, G; Li, X; Liu, L; Shen, H; Shen, M; Sun, Q; Sun, X; Wang, X; Xu, W1
Chen, B; Chen, N; Chen, W; Cheng, H; Cheng, J; Ding, J; Gao, C; Gao, F; Li, G; Li, X; Liu, L; Shen, H; Sun, Q; Sun, X; Wang, X; Wu, Y; Xu, W1
Bao, W; Chen, BA; Chen, N; Chen, W; Cheng, J; Ding, J; Gao, C; Gao, F; Li, X; Liu, L; Song, H; Sun, X; Sun, Y; Wang, X; Wu, W; Xia, G; Xu, C; Xu, W1
Chen, BA; Chen, J; Schmit, M; Shan, XY; Xia, GH; Xu, WL1
Bao, W; Cai, XH; Chen, BA; Chen, J; Cheng, J; Ding, JH; Gao, F; Shen, HL; Wang, J; Wei, HL; Xu, WL; Zhong, YJ1
Cai, X; Chen, B; Cheng, J; Liu, R; Wang, J; Wang, X; Xia, G1
Bao, W; Cai, X; Chen, B; Cheng, J; Liu, R; Ren, Y; Wang, J; Wang, X; Xia, G1
Bao, W; Cai, X; Chen, B; Cheng, J; Ding, J; Gao, C; Liu, R; Ren, Y; Song, H; Tian, L; Wang, J; Wang, L; Wang, S; Wang, X; Wu, W; Xia, G; Zhang, H1
Chen, BA; He, YJ; Jin, JF; Niu, YQ; Zhang, W1

Other Studies

11 other study(ies) available for daunorubicin and bromotetrandrine

ArticleYear
Effects of magnetic nanoparticle of fe(3)o(4) and 5-bromotetrandrine on apoptosis of K562/A02 leukemic cells induced by daunorubicin.
    Zhongguo shi yan xue ye xue za zhi, 2009, Volume: 17, Issue:1

    Topics: Apoptosis; bcl-2-Associated X Protein; Benzylisoquinolines; Daunorubicin; Down-Regulation; Ferric Compounds; Gene Expression Regulation, Leukemic; Humans; K562 Cells; Nanoparticles; Proto-Oncogene Proteins c-bcl-2; Up-Regulation

2009
Reversal of multidrug resistance in xenograft nude-mice by magnetic Fe(3)O(4) nanoparticles combined with daunorubicin and 5-bromotetrandrine.
    Zhongguo shi yan xue ye xue za zhi, 2009, Volume: 17, Issue:1

    Topics: Animals; Antineoplastic Agents; Benzylisoquinolines; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Ferric Compounds; Humans; K562 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Xenograft Model Antitumor Assays

2009
Magnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells.
    International journal of nanomedicine, 2009, Volume: 4

    Topics: Antibiotics, Antineoplastic; Apoptosis; Benzylisoquinolines; Daunorubicin; Drug Carriers; Ferric Compounds; Humans; K562 Cells; Leukemia; Nanoparticles

2009
Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice.
    International journal of nanomedicine, 2009, Volume: 4

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Benzylisoquinolines; Daunorubicin; Drug Carriers; Drug Resistance, Multiple; Ferric Compounds; Humans; K562 Cells; Leukemia; Mice; Mice, Nude; Nanoparticles; Treatment Outcome

2009
Effect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells.
    International journal of nanomedicine, 2009, Volume: 4

    Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Benzylisoquinolines; Cell Survival; Daunorubicin; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Ferrosoferric Oxide; Genes, MDR; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetics; Metal Nanoparticles; Nanomedicine; RNA, Messenger; RNA, Neoplasm

2009
Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.
    Chinese journal of cancer, 2010, Volume: 29, Issue:6

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Benzylisoquinolines; Cell Proliferation; Daunorubicin; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Leukemic; Humans; Imatinib Mesylate; K562 Cells; Piperazines; Pyrimidines; RNA, Messenger

2010
[Effects of 5-bromotetrandrine and daunorubicin on apoptosis and expression of survivin in K562/A02 cells].
    Zhongguo shi yan xue ye xue za zhi, 2011, Volume: 19, Issue:1

    Topics: Apoptosis; Benzylisoquinolines; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Humans; Inhibitor of Apoptosis Proteins; K562 Cells; Survivin

2011
Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.
    International journal of nanomedicine, 2011, Volume: 6

    Topics: Analysis of Variance; Apoptosis; Benzylisoquinolines; Daunorubicin; Delayed-Action Preparations; Drug Delivery Systems; Electrophoresis, Agar Gel; Flow Cytometry; Humans; K562 Cells; Leukemia; Magnetite Nanoparticles; Reverse Transcriptase Polymerase Chain Reaction

2011
A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.
    International journal of nanomedicine, 2011, Volume: 6

    Topics: Analysis of Variance; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Daunorubicin; Dose-Response Relationship, Drug; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; K562 Cells; Leukemia; Magnetite Nanoparticles; Microscopy, Fluorescence

2011
Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance.
    International journal of nanomedicine, 2012, Volume: 7

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; Benzylisoquinolines; Caspase 3; Combined Modality Therapy; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Hyperthermia, Induced; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Field Therapy; Magnetite Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Nanomedicine; Proto-Oncogene Proteins c-bcl-2; Xenograft Model Antitumor Assays

2012
Involvement of c-Jun N-terminal kinase in reversal of multidrug resistance of human leukemia cells in hypoxia by 5-bromotetrandrine.
    Leukemia & lymphoma, 2013, Volume: 54, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Caspase 3; Cell Hypoxia; Cell Line, Tumor; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; JNK Mitogen-Activated Protein Kinases; K562 Cells; Leukemia; Phosphorylation; RNA Interference; Signal Transduction

2013